273 related articles for article (PubMed ID: 27613122)
1. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.
Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A
Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122
[TBL] [Abstract][Full Text] [Related]
2. Ascites IL-10 Promotes Ovarian Cancer Cell Migration.
Lane D; Matte I; Garde-Granger P; Bessette P; Piché A
Cancer Microenviron; 2018 Dec; 11(2-3):115-124. PubMed ID: 30039195
[TBL] [Abstract][Full Text] [Related]
3. Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis.
Li HY; Cui XY; Wu W; Yu FY; Yao HR; Liu Q; Song EW; Chen JQ
J Cell Biochem; 2014 Mar; 115(3):596-603. PubMed ID: 24142406
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms.
Matte I; Lane D; Laplante C; Garde-Granger P; Rancourt C; Piché A
Int J Cancer; 2015 Jul; 137(2):289-98. PubMed ID: 25482018
[TBL] [Abstract][Full Text] [Related]
5. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway.
Hou X; Zhang Y; Qiao H
Tumour Biol; 2016 Jan; 37(1):641-51. PubMed ID: 26242263
[TBL] [Abstract][Full Text] [Related]
6. CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer.
Li H; Zhang D; Yu J; Liu H; Chen Z; Zhong H; Wan Y
J Cell Physiol; 2018 Apr; 233(4):3207-3217. PubMed ID: 28834540
[TBL] [Abstract][Full Text] [Related]
7. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.
Wang Q; Tang Y; Yu H; Yin Q; Li M; Shi L; Zhang W; Li D; Li L
Mol Carcinog; 2016 Nov; 55(11):1688-1699. PubMed ID: 26457987
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis.
Goncharenko-Khaider N; Matte I; Lane D; Rancourt C; Piché A
Mol Cancer; 2012 Nov; 11():84. PubMed ID: 23158473
[TBL] [Abstract][Full Text] [Related]
9. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
10. Role of Pyk2 in Human Cancers.
Shen T; Guo Q
Med Sci Monit; 2018 Nov; 24():8172-8182. PubMed ID: 30425234
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
Rosso M; Majem B; Devis L; Lapyckyj L; Besso MJ; Llauradó M; Abascal MF; Matos ML; Lanau L; Castellví J; Sánchez JL; Pérez Benavente A; Gil-Moreno A; Reventós J; Santamaria Margalef A; Rigau M; Vazquez-Levin MH
PLoS One; 2017; 12(9):e0184439. PubMed ID: 28934230
[TBL] [Abstract][Full Text] [Related]
12. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
[TBL] [Abstract][Full Text] [Related]
13. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
[TBL] [Abstract][Full Text] [Related]
14. SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro.
Zhang S; Guo D; Jiang L; Zhang Q; Qiu X; Wang E
BMC Cancer; 2008 May; 8():150. PubMed ID: 18507841
[TBL] [Abstract][Full Text] [Related]
15. Visfatin derived from ascites promotes ovarian cancer cell migration through Rho/ROCK signaling-mediated actin polymerization.
Li Y; Li X; Liu KR; Zhang JN; Liu Y; Zhu Y
Eur J Cancer Prev; 2015 May; 24(3):231-9. PubMed ID: 25055182
[TBL] [Abstract][Full Text] [Related]
16. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
Matte I; Garde-Granger P; Bessette P; Piché A
BMC Cancer; 2019 Apr; 19(1):406. PubMed ID: 31039761
[TBL] [Abstract][Full Text] [Related]
17. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
18. Store-operated Ca(2+) entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation.
Zhu M; Chen L; Zhao P; Zhou H; Zhang C; Yu S; Lin Y; Yang X
J Exp Clin Cancer Res; 2014 Nov; 33(1):98. PubMed ID: 25433371
[TBL] [Abstract][Full Text] [Related]
19. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces metalloproteinase-9 activation and human vascular smooth muscle cell migration through low-density lipoprotein receptor-related protein 1-mediated Pyk2 phosphorylation.
Revuelta-López E; Castellano J; Roura S; Gálvez-Montón C; Nasarre L; Benitez S; Bayes-Genis A; Badimon L; Llorente-Cortés V
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2877-87. PubMed ID: 24072693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
